Back
“Zyn's FDA authorization is under fire after a former agency scientist revealed the agency didn't know what the pouches were made of, raising microplastic risk that could force a costly re-review of PMI's highest-growth smoke-free product.”
Source
Matthew HerperX“Microplastic risk in Zyn pouches: Scientist ques…”span
“FDA authorized Zyn nicotine pouches without knowing what they were made of, says former agency scientist”
Performance
Entry$176.99
Current$178.11
Since call-0.63%
Confidence72%
How this was scored
Entry$176.99Jul 15, 2026 · 13:14 UTC · paste.trade
Current$178.11Jul 15, 2026 · 14:41 UTC · Finnhub
Horizonnot specifiedparsed as default-30d
Verdict bandWIN ≥ +2% · LOSS ≤ −2%
Prices are point-in-time snapshots from the named provider. The verdict compares the return since entry against the band above.